« Back
Home /
Recombinant Human ICOS/CD278 Protein

Recombinant Human ICOS/CD278 Protein

€365.00

Excl. VAT

Item no.	RP02380-100ug
Manufacturer	Abclonal
Amount	100 ug
Category	Peptides & Proteins Recombinant Proteins
Type	Proteins Recombinant
Specific against	Human (Homo sapiens)
Host	Human
Purity	> 95% by Tris-Bis PAGE;> 95% by SEC-HPLC
NCBI	ICOS/CD278
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Available
Description	Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.
Route	C-hFc
Manufacturers Category	Proteins
Endotoxin	< 1 EU/μg of the protein by LAL method.
Immunogen	Glu21-Phe141.
Storage	Store the lyophilized protein at -20°C to -80°C for long term.\|After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week.
Manufacturers Research Area	Immune Checkpoint, Bio-Markers & CD Antigens, Biosimilar Drug Targets
Gene Symbol	ICOS/CD278
Protein Formulation	Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
Protein Description	Recombinant Human ICOS/CD278 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Glu21-Phe141) of Human ICOS/CD278 fused with a hFc tag at the C-terminal.
Protein Bio Activity	Immobilized Human B7-H2, His (BH7-HM472) at 0.5μg/ml(100μl/Well) on the plate. Dose response curve for Human ICOS, hFc with the EC₅₀ of 45.6ng/ml determined by ELISA.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

Listprice: €365.00

Price: €365.00

available

Delivery expected until 9/30/2025

Quantity:

Compare